TCG Crossover Management »

Agios Pharmaceuticals shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $57M 1.4M 40.14
2025-06-30 $23M 697k 33.26

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Amylyx Pharmaceuticals Comm (AMLX)
Centessa Pharmaceuticals Adrs (CNTA)
Tango Therapeutics Comm (TNGX)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Tourmaline Bio Comm (TRML)
Dyne Therapeutics Comm (DYN)
Agios Pharmaceuticals Comm (AGIO)
Eyepoint Pharmaceuticals Comm (EYPT)
Fulcrum Therapeutics Comm (FULC)
Savara Comm (SVRA)
Rapt Therapeutics Comm (RAPT)

View all positions for TCG Crossover Management

Top funds holding Agios Pharmaceuticals

Farallon Capital Management
Vanguard Group
BlackRock
Bellevue Group
Paradigm Biocapital Advisors
Erste Asset Management GmbH
Wellington Management Company
Commodore Capital
State Street Corporation
Caligan Partners
Macquarie Group
Armistice Capital
TCG Crossover Management
Geode Capital Management
Frazier Life Sciences Management

View all funds holding Agios Pharmaceuticals